Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study

Dynamic changes of CSF sTREM2 in preclinical Alzheimer’s disease: the CABLE study

Abstract Background Loss of function of triggering receptor expressed on myeloid cell 2 (TREM2), a key receptor selectively expressed by microglia in the brain, contributes to the development of Alzheimer’s disease (AD). Whether TREM2 levels are pathologically altered during the preclinical phase, a...

Full description

Bibliographic Details
Main Authors: Ling-Zhi Ma, Lan Tan, Yan-Lin Bi, Xue-Ning Shen, Wei Xu, Ya-Hui Ma, Hong-Qi Li, Qiang Dong, Jin-Tai Yu
Format: Article
Language:English
Published: BMC 2020-04-01
Series:Molecular Neurodegeneration
Subjects:
Alzheimer’s disease
sTREM2
Inflammation
Biomarkers
Neurodegeneration
Online Access:http://link.springer.com/article/10.1186/s13024-020-00374-8

Internet

http://link.springer.com/article/10.1186/s13024-020-00374-8

Similar Items